Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
NCT01321476 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-09-05
Summary
This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Piedmont Healthcare
lead OTHER
Principal Investigators
-
Joseph Miller, MD · Piedmont Heart Institute/Piedmont Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
NCT01666704 ·Status: WITHDRAWN ·Phase: PHASE2
-
Vascular Inflammation and Cholesterol Lowering Therapy
NCT02941016 ·Status: WITHDRAWN ·Phase: PHASE4
-
Lp-PLA2 and Coronary Atherosclerosis in Humans
NCT01557088 ·Status: COMPLETED ·Phase: NA
-
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
NCT03507374 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Pioglitazone in Impaired Glucose Tolerance
NCT00306826 ·Status: WITHDRAWN ·Phase: PHASE4
-
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
NCT01602471 ·Status: TERMINATED ·Phase: PHASE2
-
Molecular Mechanisms and Carotid Atherosclerosis
NCT03962686 ·Status: COMPLETED
-
The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis
NCT01067326 ·Status: TERMINATED ·Phase: PHASE3
-
Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans
NCT02198937 ·Status: TERMINATED
-
Role of Mitophagy in Myeloid Cells During Coronary Atherosclerosis.
NCT05708547 ·Status: COMPLETED
-
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
NCT00117650 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
NCT00636766 ·Status: COMPLETED ·Phase: NA
-
The Confirmatory Olmesartan Plaque Regression Study
NCT01132768 ·Status: TERMINATED ·Phase: PHASE4
-
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
NCT01067339 ·Status: COMPLETED ·Phase: PHASE3
-
Carnitine for the Treatment of Atherosclerosis.
NCT02117661 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody
NCT04141579 ·Status: COMPLETED ·Phase: NA
-
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
NCT04277702 ·Status: UNKNOWN ·Phase: PHASE3
-
TRACER RGD-K5 Carotid Plaque Imaging Study
NCT01968226 ·Status: TERMINATED ·Phase: PHASE2
-
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
NCT02576067 ·Status: COMPLETED ·Phase: PHASE3
-
Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
NCT03320265 ·Status: TERMINATED ·Phase: PHASE2
-
Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant
NCT00228176 ·Status: TERMINATED ·Phase: PHASE3
-
Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 ·Status: WITHDRAWN
-
Prospective Carotid Artery Stenosis Trial
NCT05724836 ·Status: RECRUITING
-
PGD2 Formation in Vascular Injury
NCT01001260 ·Status: TERMINATED